Cellectricon announces Cellaxess® ACE project grant winners
September 19, 2013
Molndal, Sweden -- Cellectricon, a leading provider of advanced cell-based screening technologies and services, has announced the two winners of its Cellaxess® ACE project grant, supporting cutting-edge research in cell biology. The grant was awarded for project proposals utilizing Cellectricon’s Cellaxess ACE technology for the delivery of non-genetic material to adherent cells and cultures. The [...]
Ehrfeld Mikrotechnik BTS and Alfa Laval cooperate in millireactor technology
September 18, 2013
Wendelsheim (Germany) – Ehrfeld Mikrotechnik BTS GmbH (EMB), a subsidiary of Bayer Technology Services GmbH, has acquired a worldwide license from Alfa Laval to market and manufacture ART® reactor technology. With these millistructured plate reactors, which are used in laboratory, pilot and production plants, EMB is now the leading supplier of metal micro- and millistructured [...]
Bruker Introduces New Multimodal Preclinical Imaging Animal Bed
September 18, 2013
SAVANNAH, Ga.-- Today, at the 2013 World Molecular Imaging Congress (WMIC), Bruker (NASDAQ: BRKR) introduced a new multimodal animal bed enabling multiple sequential imaging sessions in preclinical research with robust repositioning between scans, while avoiding unwanted motion of the animal during the investigation. This innovation optimizes results for image fusion, combined processing and evaluation of [...]
September 18, 2013
SAVANNAH, GA, USA -- Aspect Imaging, the world leading developer of compact high-performance MRI systems, today launched a complete line of compact MRI systems for a wide variety of pre-clinical applications. The three “M”-series compact MRI systems include the M10, a new compact MRI model for pre-clinical imaging of larger species and the M3, a [...]
September 18, 2013
ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today released a report on the state of academic translational research, a rapidly expanding field in which academic scientists aim to "translate" their laboratory discoveries to patient benefit. The first-of-its-kind survey was conducted by Sigma-Aldrich and the Association for the Advancement of Science (AAAS) and was completed by [...]
PROTEA & VCU IN MOLECULAR IMAGING RESEARCH PARTNERSHIP
September 18, 2013
SAVANNAH, Ga. -- Protea Biosciences Group, Inc. ("Protea") announced today that it has entered into a Collaborative Research Agreement with Virginia Commonwealth University ("VCU") and its Center for Molecular Imaging. The research focuses on the combination of LAESI, Protea's ex vivo molecular imaging mass spectrometry technology platform, with VCU's in vivo molecular PET, SPECT and [...]
Core Informatics Extends it’s LIMS, ELN and SDMS Platform with 4.2 Release
September 18, 2013
Branford, CT -- Core Informatics, a leading provider of data management solutions to the life sciences, molecular diagnostics and energy industries announced today the release of Core LIMS, ELN, SDMS version 4.2. This release further extends the configurability of the Core LIMS product and enables Core’s customers to respond more promptly to their rapidly changing [...]
MMI opens new regional office in Hong Kong
September 18, 2013
After more than 15 years’ experience in the Asian Pacific region, MMI are delighted to announce the opening of MMI, Ltd. in Hong Kong, China. This is the next milestone in the MMI expansion programme. Together with the other MMI offices in Germany, Switzerland & the USA and an established distribution network in more than [...]
September 18, 2013
CARLSBAD, Calif. -- TriCore Reference Laboratories and Life Technologies Corporation (NASDAQ: LIFE) have signed an agreement to establish TriCore as a regional Next-Generation Sequencing (NGS) Center of Excellence. The partnership is part of Life's initiative to establish a global alliance comprised of leading centers capable of running the most-advanced, NGS-based oncology panels for clinical research. [...]
BioGenes Launches Enhanced Generic HCP Assay for Early Stage Biologics Production
September 18, 2013
Berlin, Germany - BioGenes GmbH, a global leader in host cell protein (HCP) assay development, today announced that it has launched a new generic HCP assay with enhanced HCP recovery properties. The CHO|360-HCP ELISA is designed to cover the broadest possible spectrum of antigens by integrating four different assay types. An upfront feasibility test will [...]
